Then please do so by first going to
(our website) and clicking on the amazon logo at the top of the page. It really is that easy!
This raises about 5% of the money spent for OMSTC and does not cost you a penny! Right now we make roughly £30 a month from this source, but it could so easily be a lot more.
Thank you to everyone who donated a raffle prize and to those who purchased tickets.
Appeal for a photocopier for the centre, this one has died, it’s done well considering it was an ex-hired machine and we do not have a maintenance contract on it. I’m not worried about size as long as it copies A4, preferably double sided.
100 club winners for September:
Total prize fund: £102.50
Diagnose and adios
“Diagnose and adios”. This was the phrase used to describe the management of multiple sclerosis (MS) up until the mid-1990s.
It’s hard to fathom today, but back then neurologists had little to offer people with MS by way of drugs and treatments and many were left to deal with complex and unpredictable symptoms alone. “Neurologists routinely told people like me ‘You’ve got MS – go home and learn to live with it’,” MS Trust co-founder Chris Jones remembers.
The landscape was bleak. MS specialist nurses were few and far between, research into the condition was limited and, understandably, hope was in short supply. Read on.
Comedian, Tanyallee Davis, recently suffered and expressed her humiliation on a train journey during which the driver insisted she move from the disabled space she was rightfully occupying, to make way for a woman boarding with a pram.
Unfortunately, the situation escalated to the point where she was taken more than 50 miles away from her destination.
Situations such as this only highlight the need for accessible venues and spaces. With that in mind, Karma Mobility – specialist suppliers of powered wheelchairs – are sharing their greatest apps for accessible travel. Find out more here.
Wheelchair World is a collection of reviews and information, found through extensive internet research or submitted directly to Wheelchair World. Visit their website here.
The government online service will guide you through the process to create a lasting power of attorney. Find out more here.
Source F1000 Prime: Fox et al. present the results of the eagerly awaited SPRINT-MS trial – a multi-centre phase II double blinded placebo controlled study of ibudilast in decreasing brain atrophy in progressive forms of multiple sclerosis (MS).
Ibudilast was previously trialled in relapsing MS and whilst it did not prevent the reduction of new T2 lesions, it had an effect on decreasing brain atrophy and conversion of gadolinium-enhancing lesions to T1 black holes. Coupled with its immunomodulation properties and ability to cross the blood-brain barrier, ibudilast was felt to be worth studying in progressive MS (PMS). Read on (click on the abstract tab)